Citadel Advisors’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Citadel Advisors’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,986	Closed	-$11K	–	14056
2022 Q2	$11K	Sell	21,986 -92,020	-81%	-$45K	﹤0.01%	12574
2022 Q1	$60K	Sell	114,006 -83,671	-42%	-$48.5K	﹤0.01%	12690
2021 Q4	$124K	Buy	+197,677	New	+$223K	﹤0.01%	12491
2021 Q2	–	Sell	-31,381	Closed	-$53K	–	14726
2021 Q1	$53K	Buy	31,381 +4,972	+19%	+$11.1K	﹤0.01%	12880
2020 Q4	$45K	Sell	26,409 -904	-3%	-$898	﹤0.01%	10605
2020 Q3	$20K	Sell	27,313 -2,708	-9%	-$2.14K	﹤0.01%	9863
2020 Q2	$25K	Buy	30,021 +13,868	+86%	+$7.1K	﹤0.01%	9507
2020 Q1	$4K	Buy	+16,153	New	+$6.43K	﹤0.01%	9502
2019 Q4	–	Sell	-75,113	Closed	-$81K	–	9975
2019 Q3	$81K	Buy	+75,113	New	+$157K	﹤0.01%	8570
2018 Q4	–	Sell	-15,378	Closed	-$33K	–	9971
2018 Q3	$33K	Buy	+15,378	New	+$43.6K	﹤0.01%	8904

Other funds holding TMDI

Essex LLC Deer Park, Illinois $659M AUM 41.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCIA

Kingsbury Capital Investment Advisors Wilmette, Illinois $65.6M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's TMDI Position: Q3 2022 in Review

Citadel Advisors sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q3 2022, closing a stake of 21,986 shares — an estimated $11K sold.

Citadel Advisors first reported a position in TMDI in Q3 2018 and held it in 10 quarters. The position peaked at $124K in Q4 2021. 55 funds tracked by Wall St. Rank hold TMDI as of Q3 2022.

Citadel Advisors reported no remaining Titan Medical Inc. Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 21,986 Titan Medical Inc. Ordinary Shares shares in Q3 2022, an estimated $11K.
Citadel Advisors first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2018 and held it in 10 quarters.
Citadel Advisors's Titan Medical Inc. Ordinary Shares position peaked at $124K in Q4 2021.
55 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.